- Home
- CELU vs OSTX Comparison
CELU vs OSTX Comparison
Compare CELU & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- OSTX
- Stock Information
- Founded
- CELU 2016
- OSTX 2018
- Country
- CELU United States
- OSTX United States
- Employees
- CELU N/A
- OSTX N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- OSTX
- Sector
- CELU Health Care
- OSTX
- Exchange
- CELU Nasdaq
- OSTX NYSE
- Market Cap
- CELU 42.2M
- OSTX 43.0M
- IPO Year
- CELU N/A
- OSTX 2024
- Fundamental
- Price
- CELU $1.98
- OSTX $1.83
- Analyst Decision
- CELU
- OSTX Strong Buy
- Analyst Count
- CELU 0
- OSTX 3
- Target Price
- CELU N/A
- OSTX $18.00
- AVG Volume (30 Days)
- CELU 75.0K
- OSTX 756.1K
- Earning Date
- CELU 05-08-2025
- OSTX 08-14-2025
- Dividend Yield
- CELU N/A
- OSTX N/A
- EPS Growth
- CELU N/A
- OSTX N/A
- EPS
- CELU N/A
- OSTX N/A
- Revenue
- CELU $54,220,000.00
- OSTX N/A
- Revenue This Year
- CELU $23.29
- OSTX N/A
- Revenue Next Year
- CELU N/A
- OSTX N/A
- P/E Ratio
- CELU N/A
- OSTX N/A
- Revenue Growth
- CELU 138.11
- OSTX N/A
- 52 Week Low
- CELU $1.00
- OSTX $1.12
- 52 Week High
- CELU $5.22
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- CELU 51.94
- OSTX N/A
- Support Level
- CELU $1.80
- OSTX N/A
- Resistance Level
- CELU $2.26
- OSTX N/A
- Average True Range (ATR)
- CELU 0.18
- OSTX 0.00
- MACD
- CELU 0.02
- OSTX 0.00
- Stochastic Oscillator
- CELU 48.25
- OSTX 0.00
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.